Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5H95B | — |
Administration to a 6 MO; 1st patient's Dtap vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B) for prophylaxis. On 08-OCT-2025, the patient received the 1st dose of Kinrix. On 08-OCT-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration to a 6 MO) and inappropriate schedule of vaccine administered (Verbatim: 1st patient's Dtap vaccine). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-OCT-2025 The registered nurse called and reported that a 6-month-old patient received Kinrix The Vaccine Administration Facility is the same as Primary Reporter", During the call, the HCP informed that they would call back due to their report was not clear about the patient being 6 month or 5 month. The health care professional informed to my coworker that this was the 1st patient's Dtap vaccine.